{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:17:56Z","timestamp":1793366276156,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T00:00:00Z","timestamp":1618099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.neo.2021.04.003","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T10:29:36Z","timestamp":1619519376000},"page":"515-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-9491","authenticated-orcid":false,"given":"Mar\u00eda","family":"Ovejero-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"Gonz\u00e1lez-Sarmiento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Bel\u00e9n","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neo.2021.04.003_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.neo.2021.04.003_bib0002","first-page":"1240","article-title":"Epithelial ovarian cancer","volume":"Vol. 393","author":"Lheureux","year":"2019"},{"issue":"1197","key":"10.1016\/j.neo.2021.04.003_bib0003","article-title":"Management of relapsed ovarian cancer: a review","volume":"5","author":"Giornelli","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.neo.2021.04.003_bib0004","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1530\/ERC-17-0336","article-title":"Biomarkers of platinum resistance in ovarian cancer: What can we use to improve treatment","volume":"25","author":"Van Zyl","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.neo.2021.04.003_bib0005","first-page":"11","article-title":"Chemotherapy resistance in advanced ovarian cancer patients","author":"Pokhriyal","year":"2019","journal-title":"Biomark Cancer"},{"issue":"7","key":"10.1016\/j.neo.2021.04.003_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neo.2021.04.003_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00092","article-title":"Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: Achieving the full therapeutic potential of HDACi","volume":"8","author":"Suraweera","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.neo.2021.04.003_bib0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.neo.2021.04.003_bib0009","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4161\/epi.1.1.2644","article-title":"Histone deacetylase inhibitors for cancer therapy","volume":"1","author":"Kim","year":"2006","journal-title":"Epigenetics"},{"key":"10.1016\/j.neo.2021.04.003_bib0010","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1111\/febs.13746","article-title":"How do tumor cells respond to HDAC inhibition?","volume":"283","author":"Newbold","year":"2016","journal-title":"FEBS J"},{"key":"10.1016\/j.neo.2021.04.003_bib0011","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.neo.2021.04.003_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-017-0495-y","article-title":"Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair","volume":"10","author":"L\u00f3pez-Iglesias","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.neo.2021.04.003_bib0013","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2016.07.088","article-title":"Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib","volume":"143","author":"Wilson","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.neo.2021.04.003_bib0014","doi-asserted-by":"crossref","first-page":"19482","DOI":"10.1073\/pnas.0707828104","article-title":"HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination","volume":"104","author":"Adimoolam","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.neo.2021.04.003_bib0015","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1535-7163.MCT-12-1242","article-title":"Histone deacetylase regulation of ATM-mediated DNA damage signaling","volume":"12","author":"Thurn","year":"2013","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.neo.2021.04.003_bib0016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12935-016-0306-5","article-title":"The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines","volume":"16","author":"de Andrade","year":"2016","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.neo.2021.04.003_bib0017","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00280-018-3669-6","article-title":"Autophagy modulation: a prudent approach in cancer treatment?","volume":"82","author":"Bishop","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.neo.2021.04.003_bib0018","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/j.1582-4934.2009.00832.x","article-title":"Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation","volume":"14","author":"Carew","year":"2010","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.neo.2021.04.003_bib0019","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1158\/1535-7163.MCT-11-0979","article-title":"Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells","volume":"11","author":"Rao","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.neo.2021.04.003_bib0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood-2006-10-050260","article-title":"Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance","volume":"110","author":"Carew","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.neo.2021.04.003_bib0021","first-page":"4345","article-title":"Histone deacetylase inhibitor trichostatin a and autophagy inhibitor chloroquine synergistically exert anti-tumor activity in H-ras transformed breast epithelial cells","volume":"17","author":"Gao","year":"2018","journal-title":"Mol Med Rep"},{"issue":"1\u20132","key":"10.1016\/j.neo.2021.04.003_bib0022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11010-020-03708-8","article-title":"Inhibition of JNJ-26481585-mediated autophagy induces apoptosis via ROS activation and mitochondrial membrane potential disruption in neuroblastoma cells","volume":"468","author":"Kommalapati","year":"2020","journal-title":"Mol Cell Biochem"},{"issue":"14","key":"10.1016\/j.neo.2021.04.003_bib0023","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2013-05-500629","article-title":"Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells","volume":"122","author":"Torgersen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.neo.2021.04.003_bib0024","first-page":"1608","article-title":"Chloroquine analogues in drug discovery: New directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases","volume":"70","author":"AA","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.neo.2021.04.003_bib0025","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.neo.2021.04.003_bib0026","first-page":"781","article-title":"Repurposing drugs in oncology (ReDO) - Chloroquine and hydroxychloroquine as anti-cancer agents","volume":"11","author":"Verbaanderd","year":"2017","journal-title":"Ecancer-medicalscience"},{"key":"10.1016\/j.neo.2021.04.003_bib0027","doi-asserted-by":"crossref","DOI":"10.4161\/auto.8.2.18554","article-title":"Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy","volume":"8","author":"Maycotte","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.neo.2021.04.003_bib0028","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1073\/pnas.1515617113","article-title":"Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy","volume":"113","author":"Eng","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neo.2021.04.003_bib0029","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/CAD.0b013e32835a36db","article-title":"Chloroquine overcomes resistance of lung carcinoma cells to the dual PI3K\/mTOR inhibitor PI103 by lysosome-mediated apoptosis","volume":"24","author":"Enzenm\u00fcller","year":"2013","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.neo.2021.04.003_bib0030","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.dnarep.2008.06.018","article-title":"Comparison of nonhomologous end joining and homologous recombination in human cells","volume":"7","author":"Mao","year":"2008","journal-title":"DNA Repair (Amst)"},{"issue":"17","key":"10.1016\/j.neo.2021.04.003_bib0031","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1073\/pnas.1204429109","article-title":"Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death","volume":"109","author":"Gammoh","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"8","key":"10.1016\/j.neo.2021.04.003_bib0032","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4161\/auto.6.8.13365","article-title":"Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma","volume":"6","author":"Liu","year":"2010","journal-title":"Autophagy"},{"issue":"52","key":"10.1016\/j.neo.2021.04.003_bib0033","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.0408345102","article-title":"Apoptotic and autophagic cell death induced by histone deacetylase inhibitors","volume":"101","author":"Shao","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"10.1016\/j.neo.2021.04.003_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111703","article-title":"A new histone deacetylase inhibitor enhances radiation sensitivity through the induction of misfolded protein aggregation and autophagy in triple-negative breast cancer","volume":"11","author":"Chiu","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.neo.2021.04.003_bib0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/glia.20017","article-title":"Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells","volume":"47","author":"Pare","year":"2004","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.neo.2021.04.003_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173712","article-title":"Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS","volume":"12","author":"Qu","year":"2017","journal-title":"PLoS One"},{"issue":"PB","key":"10.1016\/j.neo.2021.04.003_bib0037","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.biochi.2014.10.001","article-title":"Inhibition of autophagy by chloroquine potentiates synergistically anti-cancer property of artemisinin by promoting ROS dependent apoptosis","volume":"107","author":"Ganguli","year":"2014","journal-title":"Biochimie"},{"issue":"10","key":"10.1016\/j.neo.2021.04.003_bib0038","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1158\/1535-7163.MCT-08-0385","article-title":"Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824\/fludarabine antileukemic interactions","volume":"7","author":"Rosato","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"19","key":"10.1016\/j.neo.2021.04.003_bib0039","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1073\/pnas.191208598","article-title":"The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species","volume":"98","author":"Ruefli","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.neo.2021.04.003_bib0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.12717\/DR.2014.18.4.225","article-title":"Biphasic activity of Chloroquine in human colorectal cancer cells","volume":"18","author":"Park","year":"2014","journal-title":"Dev Reprod"},{"key":"10.1016\/j.neo.2021.04.003_bib0041","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.redox.2014.12.003","article-title":"Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy","volume":"4","author":"Poillet-Perez","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.neo.2021.04.003_bib0042","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/jcb.21067","article-title":"The cellular control of DNA double-strand breaks","volume":"99","author":"Scott","year":"2006","journal-title":"J Cell Biochem. NIH Public Access"},{"key":"10.1016\/j.neo.2021.04.003_bib0043","volume":"Vol. 25","author":"Srinivas","year":"2019"},{"issue":"3","key":"10.1016\/j.neo.2021.04.003_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121581","article-title":"Deregulation of DNA double-strand break repair in multiple myeloma: Implications for genome stability","volume":"10","author":"Herrero","year":"2015","journal-title":"PLoS One"},{"issue":"MAY","key":"10.1016\/j.neo.2021.04.003_bib0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fonc.2017.00098","article-title":"Targeting ongoing DNA damage in multiple myeloma: Effects of DNA damage response inhibitors on plasma cell survival","volume":"7","author":"Herrero","year":"2017","journal-title":"Front Oncol"},{"issue":"14","key":"10.1016\/j.neo.2021.04.003_bib0046","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1158\/1078-0432.CCR-15-1063","article-title":"HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR repair to sensitize cells to sapacitabine in acute myelogenous leukemia","volume":"22","author":"Lai","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.neo.2021.04.003_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011208","article-title":"Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor","volume":"5","author":"Kachhap","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2021.04.003_bib0048","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s13277-013-1134-z","article-title":"Inhibition of autophagy induced by TSA sensitizes colon cancer cell to radiation","volume":"35","author":"He","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.neo.2021.04.003_bib0049","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2021.04.003_bib0050","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/88.11.699","article-title":"The search for cytotoxic synergy between anticancer agents: a case of Dorothy and the ruby slippers?","volume":"88","author":"Greco","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.neo.2021.04.003_bib0051","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cell.2009.05.023","article-title":"p62 at the crossroads of autophagy, apoptosis, and cancer","volume":"137","author":"Moscat","year":"2009","journal-title":"Cell."},{"key":"10.1016\/j.neo.2021.04.003_bib0052","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.febslet.2010.02.017","article-title":"Physiological significance of selective degradation of p62 by autophagy","volume":"584","author":"Komatsu","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neo.2021.04.003_bib0053","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","article-title":"Principles and current strategies for targeting autophagy for cancer treatment","volume":"17","author":"Amaravadi","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"3A","key":"10.1016\/j.neo.2021.04.003_bib0054","first-page":"1585","article-title":"Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines","volume":"28","author":"Yamamoto","year":"2008","journal-title":"Anticancer Res"},{"issue":"50","key":"10.1016\/j.neo.2021.04.003_bib0055","doi-asserted-by":"crossref","first-page":"83476","DOI":"10.18632\/oncotarget.13080","article-title":"Autophagy as an emerging therapy target for ovarian carcinoma","volume":"7","author":"Zhan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2021.04.003_bib0056","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2019-9-1","article-title":"Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues","volume":"8","author":"Shukla","year":"2019","journal-title":"Drugs Context"},{"key":"10.1016\/j.neo.2021.04.003_bib0057","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3892\/or.2015.4380","article-title":"Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo","volume":"35","author":"Hu","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.neo.2021.04.003_bib0058","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10565-006-0173-2","article-title":"Genotoxicity of chloroquine in rat liver cells: Protective role of free radical scavengers","volume":"22","author":"Farombi","year":"2006","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.neo.2021.04.003_bib0059","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1158\/1078-0432.CCR-03-0561","article-title":"Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors","volume":"10","author":"Pei","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.neo.2021.04.003_bib0060","first-page":"3637","article-title":"The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1\/WAF1","volume":"63","author":"Rosato","year":"2003","journal-title":"Cancer Res"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558621000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558621000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:08:06Z","timestamp":1761484086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558621000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1476558621000233"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2021.04.003","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2021.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}